CHARLES GEORGE EBERHART, M.D.
Medical Practice at Wolfe St, Baltimore, MD
License number
Maryland D57110
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-2660
Personal information
See more information about CHARLES GEORGE EBERHART at radaris.comName
Address
Phone
323 Murdock Rd, Baltimore, MD 21212
323 Murdock Rd, Baltimore, MD 21212
8311 Tally Ho Rd, Lutherville Timonium, MD 21093
3001 Cresmont Ave, Baltimore, MD 21211
Professional information
See more information about CHARLES GEORGE EBERHART at trustoria.com
Professor Of Pathology, Ophthalmology And Oncology At Johns Hopkins University
Professor Of Pathology, Ophthalmology And Oncology At Johns Hopkins University
Position:
Professor at Johns Hopkins University
Location:
Baltimore, Maryland Area
Industry:
Higher Education
Work:
Johns Hopkins University
- Baltimore, Maryland Area since Jul 1997
-
Professor
Education:
UT Southwestern Medical School 1989 - 1997
MD PhD, Medicine, Developmental Biology Max Planck Institute 1988 - 1989
Research Fellow, Molecular Biology UT Austin 1983 - 1988
BA, Biochemistry
MD PhD, Medicine, Developmental Biology Max Planck Institute 1988 - 1989
Research Fellow, Molecular Biology UT Austin 1983 - 1988
BA, Biochemistry
Dr. Charles G Eberhart, Baltimore MD - MD (Doctor of Medicine)
Dr. Charles G Eberhart, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Neuropathology
Address:
Baltimore Office
600 N Wolfe St SUITE 100, Baltimore 21287
(410) 955-6230 (Phone)
600 N Wolfe St SUITE 100, Baltimore 21287
(410) 955-6230 (Phone)
Certifications:
Anatomic Pathology, 2003, Neuropathology, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Baltimore Office
600 N Wolfe St SUITE 100, Baltimore 21287
Howard County General Hospital
5755 Cedar Ln, Columbia 21044
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
600 N Wolfe St SUITE 100, Baltimore 21287
Howard County General Hospital
5755 Cedar Ln, Columbia 21044
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
University Of Texas Southwestern Medical Center At Dallas
Graduated: 1997
Johns Hopkins University School Med
University Of Texas Southwestern Medical Center At Dallas
Graduated: 1997
Johns Hopkins University School Med
Charles George Eberhart, Baltimore MD
Charles George Eberhart, Baltimore MD
Specialties:
Pathology, Anatomic Pathology, Neuropathology, Anatomic Pathology & Clinical Pathology
Work:
The Johns Hopkins Hospital
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287
Education:
The University of Texas Southwestern (1997)
Charles George Eberhart, Baltimore MD
Charles George Eberhart, Baltimore MD
Specialties:
Pathologist
Address:
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology), American Board of Pathology Sub-certificate in Neuropathology (Pathology)
Cancer Treatment With Gama-Secretase Inhibitors
Cancer Treatment With Gama-Secretase Inhibitors
US Patent:
2011002, Jan 27, 2011
Filed:
Mar 25, 2010
Appl. No.:
12/731477
Inventors:
Charles Eberhart - Baltimore MD, US
Xing Fan - Lutherville MD, US
Anirban Maitra - Baltimore MD, US
Xing Fan - Lutherville MD, US
Anirban Maitra - Baltimore MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
A61K 31/381, A61P 35/00, A61K 31/5513, A61K 49/00, A61K 38/43, A61K 39/395, A61K 39/00, A61P 35/02
US Classification:
424 92, 514445, 514221, 424 941, 4241301, 4241841
Abstract:
Provided are methods for treating cancer in a patient, comprising administering to a patient in need thereof a therapeutically effective regimen, the regimen comprising administering a gamma-secretase inhibitor, wherein the regimen results in a reduction in the cancer cell population in the patient. In some embodiments of the methods, the therapeutically effective regimen stabilizes, reduces or eliminates the cancer stem cell population.Also provided are compounds of the formula Ior a pharmaceutically acceptable salt thereof, wherein R, R, and X are as herein described.
Cancer Treatment With Gama-Secretase Inhibitors
Cancer Treatment With Gama-Secretase Inhibitors
US Patent:
2008005, Mar 6, 2008
Filed:
Feb 27, 2007
Appl. No.:
11/712292
Inventors:
Charles Eberhart - Baltimore MD, US
Xing Fan - Lutherville MD, US
Anirban Maitra - Baltimore MD, US
Xing Fan - Lutherville MD, US
Anirban Maitra - Baltimore MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
A61K 31/38, A61K 31/55, A61P 43/00
US Classification:
514221000, 514445000
Abstract:
Provided are methods for treating cancer in a patient, comprising administering to a patient in need thereof a therapeutically effective regimen, the regimen comprising administering a gamma-secretase inhibitor, wherein the regimen results in a reduction in the cancer cell population in the patient. In some embodiments of the methods, the therapeutically effective regimen stabilizes, reduces or eliminates the cancer stem cell population.
Also provided are compounds of the formula I
or a pharmaceutically acceptable salt thereof, wherein R, R, and X are as herein described.